COHU · XBRL financial data
Cohu financial statements, every quarter
The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (COHU's year ends in late December)
| In millions of dollars | Dec 30, 2023 | Mar 30, 2024 | Jun 29, 2024 | Sep 28, 2024 | Dec 28, 2024 | Mar 29, 2025 | Jun 28, 2025 | Sep 27, 2025 | Dec 27, 2025 | Mar 28, 2026 | Jun 27, 2026 | Sep 26, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | 22* | 22 | 21 | 20 | 21* | 23 | 23 | 22 | 23* | 26 | 25 | 26 |
| Selling, general and administrative | 33* | 35 | 32 | 30 | 31* | 30 | 30 | 32 | 32* | 35 | 34 | 33 |
| Operating income (loss) | 0* | (18) | (16) | (16) | (22)* | (27) | (17) | (10) | (15)* | (11) | 0 | 13 |
| Interest expense | 1* | 0 | 0 | 0 | 0* | 0 | 0 | 0 | 2* | 2 | 2 | 2 |
| Income tax expense (benefit) | 2* | (2) | 1 | 3 | 2* | 5 | 2 | (4) | 9* | 3 | 2 | 2 |
| Net income (loss) | (2)* | (15) | (16) | (18) | (21)* | (31) | (17) | (4) | (22)* | (12) | (0) | 12 |
| Earnings per share, basic USD per share | (0.04)* | (0.31) | (0.34) | (0.39) | (0.46)* | (0.66) | (0.36) | (0.09) | (0.48)* | (0.26) | 0.00 | 0.26 |
| Earnings per share, diluted USD per share | (0.04)* | (0.31) | (0.34) | (0.39) | (0.46)* | (0.66) | (0.36) | (0.09) | (0.48)* | (0.26) | 0.00 | 0.22 |
| Weighted average shares, basic millions of shares | 47* | 47 | 47 | 47 | 47* | 47 | 47 | 47 | 47* | 47 | 47 | 47 |
| Weighted average shares, diluted millions of shares | 48* | 47 | 47 | 47 | 47* | 47 | 47 | 47 | 47* | 47 | 47 | 54 |
Balance sheet
CSVFiscal quarters (COHU's year ends in late December)
| In millions of dollars | Dec 30, 2023 | Mar 30, 2024 | Jun 29, 2024 | Sep 28, 2024 | Dec 28, 2024 | Mar 29, 2025 | Jun 28, 2025 | Sep 27, 2025 | Dec 27, 2025 | Mar 28, 2026 | Jun 27, 2026 | Sep 26, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | 246 | 191 | 203 | 189 | 206 | 152 | 164 | 150 | 227 | 211 | 220 | 272 |
| Short-term investments | 90 | 80 | 59 | 80 | 56 | 49 | 45 | 48 | 257 | 278 | 279 | 236 |
| Inventory | 156 | 152 | 146 | 144 | 142 | 139 | 138 | 134 | 129 | 131 | 140 | 149 |
| Total current assets | 639 | 573 | 546 | 542 | 534 | 479 | 491 | 514 | 750 | 754 | 789 | 836 |
| Property and equipment, net | 69 | 76 | 75 | 77 | 75 | 76 | 77 | 77 | 77 | 77 | 75 | 75 |
| Right-of-use asset | 17 | 16 | 15 | 14 | 14 | 13 | 32 | 31 | 29 | 28 | 28 | 27 |
| Goodwill | 242 | 238 | 237 | 243 | 235 | 273 | 283 | 282 | 283 | 280 | 279 | 279 |
| Total assets | 1,150 | 1,074 | 1,039 | 1,032 | 999 | 976 | 1,010 | 1,021 | 1,243 | 1,235 | 1,258 | 1,298 |
| Accounts payable | 34 | 30 | 22 | 23 | 31 | 31 | 41 | 51 | 41 | 49 | 62 | 77 |
| Current portion of long-term debt | 6 | 3 | 2 | 3 | 2 | 11 | 11 | 11 | 11 | 11 | 11 | 17 |
| Total current liabilities | 103 | 91 | 79 | 85 | 85 | 92 | 101 | 117 | 109 | 117 | 137 | 162 |
| Long-term debt | 34 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 285 | 285 | 285 | 285 |
| Lease liability, non-current | 13 | 13 | 11 | 10 | 10 | 9 | 32 | 32 | 32 | 31 | 31 | 30 |
| Retained earnings | 319 | 304 | 288 | 270 | 249 | 218 | 201 | 197 | 174 | 162 | 162 | 174 |
| Total stockholders' equity | 950 | 915 | 896 | 885 | 857 | 828 | 831 | 831 | 786 | 769 | 775 | 791 |
| Total liabilities and equity | 1,150 | 1,074 | 1,039 | 1,032 | 999 | 976 | 1,010 | 1,021 | 1,243 | 1,235 | 1,258 | 1,298 |
| Common shares outstanding (cover page) millions of shares | 47 | 47 | 47 | 47 | 47 | 47 | 47 | 47 | 47 | 47 | 47 | 47 |
Cash flows
CSVFiscal quarters (COHU's year ends in late December)
| In millions of dollars | Dec 30, 2023 | Mar 30, 2024 | Jun 29, 2024 | Sep 28, 2024 | Dec 28, 2024 | Mar 29, 2025 | Jun 28, 2025 | Sep 27, 2025 | Dec 27, 2025 | Mar 28, 2026 | Jun 27, 2026 | Sep 26, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | (2)* | (15) | (16) | (18) | (21)* | (31) | (17) | (4) | (22)* | (12) | (0) | 12 |
| Stock-based compensation | 5* | 5 | 6* | 5* | 5* | 6 | 6* | 6* | 5* | 6 | 7* | 5* |
| Depreciation and amortization | 13* | 13 | 13* | 13* | 13* | 13 | 13* | 14* | 11* | 10 | 10* | 10* |
| Net cash from operating activities | 3* | (14) | 1* | 17* | (2)* | (10) | 16* | (14)* | year only | 10 | 10* | 6* |
| Purchases of property and equipment | 4* | 3 | 2* | 2* | 3* | 11 | 3* | 4* | 3* | 2 | 2* | 3* |
| Net cash from investing activities | (42)* | 7 | 19* | (22)* | 18* | (34) | (1)* | (13)* | (210)* | (22) | (1)* | 41* |
| Proceeds from issuing common stock | year only | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | 13* | 11 | 8* | 8* | 0* | 8 | 0* | (0)* | 0* | 0 | 0* | 0* |
| Repayments of long-term debt | 1* | 30 | 1* | 0* | 1* | 0 | 0* | 0* | 1* | 0 | 0* | 0* |
| Net cash from financing activities | (12)* | (44) | (7)* | (8)* | 1* | (2) | 1* | (0)* | 248* | (5) | 1* | 5* |
| Net change in cash | (48)* | (54) | 12* | (14)* | 17* | (55) | 13* | (14)* | 77* | (16) | 9* | 53* |
Compare with peers
SIC 3825 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3825 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Cohu | 272 | 173 | 5.6* | 47.3M | — | 10-QSep 26, 2026 |
| Aehr Test Systems | 116 | 19* | 1.8* | 32.6M | — | 10-KMay 29, 2026 |
| Transcat | 5.8 | 97 | 10* | 9.4M | — | 10-QSep 26, 2026 |
| EyePoint | 110 | 0.5 | (62)* | 86.2M | 2.9 quarters | 10-QJun 30, 2026 |
| 10x Genomics | 503 | 151 | 17* | not reported | — | 10-QJun 30, 2026 |
| Allient | 42 | 154 | 14* | 17.0M | — | 10-QJun 30, 2026 |
| Onto Innovation | 1,253 | 343 | 62* | 49.1M | — | 10-QJun 30, 2026 |
| Cytek Biosciences | 74 | 48 | 1.4* | 130.0M | — | 10-QJun 30, 2026 |
| Senseonics Holdings | 45 | 14 | (30)* | 52.9M | 4.7 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.